| 1. |
Romano-Zelekha O, Hirsh R, Blieden L, Green M, Shohat T. The risk forcongenital heart defects in offspring of individuals with congenital heartdefects. Clin Genet 2001;59:325-9.
|
| 2. |
Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: The changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001;37:1170-5.
|
| 3. |
Frässdorf J, De Hert S, Schlack W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth 2009;103:89-98.
|
| 4. |
Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase-2. Anesthesiology 2004;100:525-31.
|
| 5. |
Hemmerling T, Olivier JF, Le N, Prieto I, Bracco D. Myocardial protection byisoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pumpaortocoronary bypass grafting. Eur J Anaesthesiol 2008;25:230-6.
|
| 6. |
Bray RJ. Fatal myocardial failure associated with a propofol infusion in achild. Anaesthesia 1995;50:94.
|
| 7. |
Diao S, Ni J, Shi X, Liu P, Xia W. Mechanisms of action of general anesthetics. Front Biosci (Landmark Ed) 2014;19:747-57.
|
| 8. |
Zvara DA, Bryant AJ, Deal DD, DeMarco MP, Campos KM, Mansfield CM, et al. Anesthetic preconditioning with sevoflurane does not protect the spinal cord after an ischemic-reperfusion injury in the rat. Anesth Analg 2006;102:1341-7.
|
| 9. |
Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005;94:159-65.
|
| 10. |
Malagon I, Hogenbirk K, van Pelt J, Hazekamp MG, Bovill JG. Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery. Br J Anaesth 2005;94:805-9.
|
| 11. |
Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al.; Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acutecardiac care. Eur Heart J 2010;31:2197-204.
|
| 12. |
Imantalab V, SeddighiNejad A, Mir Mansouri A, SadeghiMeibodi A, Haghighi M, Dadkhah H, et al. A comparative study of cardioprotective effect of three anesthetic agents by measuring serum level of troponin-T after coronary artery bypass grafting. Int Cardiovasc Res J 2012;6:70-4.
|
| 13. |
Pierpont GL, McFalls EO. Interpreting troponin elevations: Do we need multiple diagnoses? Eur Heart J 2009;30:135-8.
|
| 14. |
Flier S, Post J, Concepcion AN, Kappen TH, Kalkman CJ, Buhre WF. Influence of propofol-opioid vsisoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br J Anaesth 2010;105:122-30.
|
| 15. |
Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: A comparison with isoflurane. Anesth Analg 2006;103:527-32.
|